Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database.

Gil-Chun Park Shin Hwang Myoung Soo Kim Dong Hwan Jung Ki Won Song Kwang-Woong Lee Jong Man Kim Jae Geun Lee Je Ho Ryu Dong Lak Choi Hee-Jung Wang Bong-Wan Kim Young Dong Yu Yang Won Nah Young Kyoung You Koo Jeong Kang Hee Chul Yu Yo-Han Park Kyung Jin Lee Yun Kyu Kim

Published in: Journal of Korean medical science (2020)

Combination therapy is the mainstay of HBV prophylaxis protocols in a majority of Korean LT centers, but HBIG was often administered excessively. Individualized optimization of HBIG treatments using SHL is necessary to adjust the HBIG infusion interval.

Keyphrases

combination therapy
hepatitis b virus
low dose
adverse drug